BioSpace News Archive

Business

Mallinckrodt plc Reports Second Quarter 2018 Results and Raises Guidance for 2018

Net sales of $631.7 million, up 5.3%, or 5.0% on a constant-currency basis

August 7, 2018
·
23 min read
Business

Haemonetics 1st Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website

Financial release accessible online

August 7, 2018
·
1 min read
Drug Development

Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

Jeffrey Berger, M.D.

August 7, 2018
·
12 min read
Business

Symbility Helps Aviva Enhance Policyholders’ Claim and Risk Management Experience

Aviva has adopted LINK, Symbility’s collaborative cloud-based platform to improve the claims experience for its UK home and commercial property customers.

August 7, 2018
·
5 min read
Policy

Innovus Pharma Announces Three Regulatory Filings with Health Canada for Its Products: Xyralid® Suppositories, Beyond Human® Testosterone and RecalMax™

The Three Potential Products, If Approved, Will Supplement the Company’s Eight Products Launched in Canada to Date

August 7, 2018
·
4 min read
BioMidwest

Monroe Capital Supports Galen Partners’ Recapitalization of SMP Pharmacy Solutions

Based in Miami, Florida, SMP is a high-touch, service-oriented specialty pharmacy that focuses on niche and complex therapeutic areas such as fertility.

August 7, 2018
·
1 min read
Business

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China

Synergy Pharmaceuticals Inc. announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin) providing Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE® (plecanatide)

August 7, 2018
·
6 min read
BioForest

EchoNous Reinvents Hosting System for Clinical Nursing Tools, Announcing New AI Station™ Aimed at Lowering Health System Costs

A blank sheet, a Nike designer, and advice from top health systems to create a platform raising convenience for nurses through clinical functionality and premium material performance

August 7, 2018
·
4 min read
Business

Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements

Positive Phase 2 Clinical Results

August 7, 2018
·
14 min read
Business

Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors

Dr. Fatmi qualifies as an independent director under the Nasdaq Rules.

August 7, 2018
·
4 min read